TickerGuard
Buy Day today: Neutral (57) Mixed market breadth · no major macro event
VKTX

Viking Therapeutics Inc

Healthcare · Biotechnology

28.50$ +2.8% vs. previous close Closing price · As of: Oct 9, 2026

Statements

Income Statement

All figures per share in USD.

Tick rows to compare them in a chart (up to 4)

Income Statement VKTX
Line item 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– – 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
– – 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
– – 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
0.19 0.00 5.16 1.10 0.55 0.53 0.33 0.33 0.44 0.58 0.71 0.68 0.93 3.06
0.11 0.02 0.29 0.79 0.30 0.21 0.12 0.13 0.15 0.14 0.21 0.39 0.45 0.43
0.30 0.02 5.45 1.89 0.85 0.73 0.45 0.45 0.59 0.72 0.92 1.07 1.38 3.49
-0.30 -0.02 -5.45 -1.89 -0.85 -0.73 -0.45 -0.45 -0.59 -0.72 -0.92 -1.07 -1.38 -3.49
– 0.01 0.15 0.16 0.12 0.08 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00
-0.30 -0.03 -5.08 -3.68 -0.90 -0.79 -0.38 -0.36 -0.54 -0.71 -0.90 -0.91 -1.01 -3.19
0.00 0.01 0.15 0.15 0.12 0.07 -0.05 0.10 -0.05 -0.01 -0.02 0.00 -1.01 –
-0.30 -0.03 -5.08 -3.68 -0.90 -0.79 -0.38 -0.36 -0.54 -0.71 -0.90 -0.91 -1.01 -3.19
-73.93 -0.03 -4.93 -3.36 0.07 0.02 0.08 -0.35 0.05 -0.71 -0.89 -1.07 -1.00 -3.19

Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?